We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
UFP Industries
UFPI
$4.9B
| $1.53M | ﹤0.01% |
107,547
+570
| +0.5% | +$8.79K |
|
|
IPHS
1502
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.53M | ﹤0.01% |
27,782
-80
| -0.3% | -$4.64K |
|
1503
California Water Service
CWT
$3.1B
| $1.53M | ﹤0.01% |
68,083
| – | – |
|
1504
Opko Health
OPK
$985M
| $1.52M | ﹤0.01% |
178,822
-85
| -0% | -$747 |
|
1505
Tennant Co
TNC
$1.43B
| $1.52M | ﹤0.01% |
22,672
-20
| -0.1% | -$1.44K |
|
|
KAMN
1506
DELISTED
Kaman Corp
KAMN
| $1.52M | ﹤0.01% |
38,611
-100
| -0.3% | -$4.09K |
|
|
CUB
1507
DELISTED
Cubic Corporation
CUB
| $1.52M | ﹤0.01% |
32,424
+80
| +0.2% | +$3.58K |
|
|
MRC
1508
DELISTED
MRC Global
MRC
| $1.51M | ﹤0.01% |
64,835
+607
| +0.9% | +$15.6K |
|
1509
Churchill Downs
CHDN
$5.88B
| $1.51M | ﹤0.01% |
92,958
-600
| -0.6% | -$9.22K |
|
|
FNSR
1510
DELISTED
Finisar Corp
FNSR
| $1.51M | ﹤0.01% |
90,839
-6,170
| -6% | -$119K |
|
1511
Clearwater Paper
CLW
$339M
| $1.51M | ﹤0.01% |
25,111
-850
| -3% | -$56.2K |
|
|
NFBK
1512
DELISTED
Northfield Bancorp
NFBK
| $1.51M | ﹤0.01% |
110,665
+39,450
| +55% | +$518K |
|
1513
Neogen
NEOG
$2.63B
| $1.5M | ﹤0.01% |
101,493
+400
| +0.4% | +$6.31K |
|
|
FSL
1514
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $1.5M | ﹤0.01% |
76,555
+437
| +0.6% | +$9.33K |
|
|
EBIX
1515
DELISTED
Ebix Inc
EBIX
| $1.5M | ﹤0.01% |
105,442
-12,450
| -11% | -$173K |
|
1516
S&T Bancorp
STBA
$1.84B
| $1.47M | ﹤0.01% |
62,710
-100
| -0.2% | -$2.46K |
|
1517
Royal Bank of Canada
RY
$291B
| $1.47M | ﹤0.01% |
20,560
| – | – |
|
|
ECOL
1518
DELISTED
US Ecology, Inc.
ECOL
| $1.47M | ﹤0.01% |
31,394
-4,180
| -12% | -$192K |
|
|
AYR
1519
DELISTED
Aircastle Ltd
AYR
| $1.47M | ﹤0.01% |
89,752
-170
| -0.2% | -$3.09K |
|
|
SONC
1520
DELISTED
Sonic Corp
SONC
| $1.47M | ﹤0.01% |
65,641
-800
| -1% | -$17.3K |
|
1521
Cato Corp
CATO
$68.3M
| $1.47M | ﹤0.01% |
42,557
-27,098
| -39% | -$903K |
|
|
AUXL
1522
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $1.47M | ﹤0.01% |
49,155
-4,460
| -8% | -$94.5K |
|
|
BPFH
1523
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.46M | ﹤0.01% |
117,770
+470
| +0.4% | +$5.93K |
|
1524
Apogee Enterprises
APOG
$826M
| $1.46M | ﹤0.01% |
36,579
+50
| +0.1% | +$1.77K |
|
1525
NBT Bancorp
NBTB
$2.74B
| $1.46M | ﹤0.01% |
64,597
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.